Daxor (FRA:DX5) Operating Cash Flow per Share : €-0.32 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Daxor Operating Cash Flow per Share?

Daxor's operating cash flow per share for the six months ended in Jun. 2024 was €-0.17. Daxor's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.32.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Daxor's Operating Cash Flow per Share or its related term are showing as below:

FRA:DX5' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -133 Med: -24.7 Max: 61.1
Current: -8.3

During the past 13 years, Daxor's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.10% per year. The lowest was -133.00% per year. And the median was -24.70% per year.

FRA:DX5's 3-Year OCF Growth Rate is ranked worse than
64.23% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 3.2 vs FRA:DX5: -8.30

Daxor Operating Cash Flow per Share Historical Data

The historical data trend for Daxor's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daxor Operating Cash Flow per Share Chart

Daxor Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.75

-0.51

-0.61

-0.18

-0.72

Daxor Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.11	-0.06	-0.59	-0.15	-0.17

Competitive Comparison of Daxor's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Daxor's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daxor's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daxor's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Daxor's Price-to-Operating-Cash-Flow falls into.

Daxor Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Daxor's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-3.352	/	4.631
	=	-0.72

Daxor's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-0.831	/	4.830
	=	-0.17

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.32

Daxor Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Daxor's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Daxor Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

DXR:USA

Address

109 Meco Lane, Oak Ridge, TN, USA, 37830

Website

https://www.daxor.com

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor Headlines

No Headlines